Skip to main content

Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.

Author
Abstract
:

The efficacy, safety and immunogenicity risk of switching between an originator biologic and a biosimilar or from one biosimilar to another are of potential concern.

Year of Publication
:
2018
Journal
:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Date Published
:
2018
ISSN Number
:
1173-8804
URL
:
https://dx.doi.org/10.1007/s40259-017-0256-z
DOI
:
10.1007/s40259-017-0256-z
Short Title
:
BioDrugs
Download citation